ALCHEMIA'S CEO DEPARTS
Written on the 11 November 2014
ALCHEMIA (ASX: ACL) is getting a new face.
The drug discovery and development company has announced the departure of Thomas Liquard as CEO.
In the interim, former ACL CEO Tracie Ramsdale will step up from a non-executive director role into an executive director capacity.
The company noted in an announcement that Ramsdale’s leadership will help them during this transition, and ended with thanking Liquard “for his efforts and wishing him well for the future”.